Carvin Medicines

Carvin Medicines is a global biopharmaceutical company dedicated to the development of next-generation psychedelic medicines. With a focus on innovation and therapeutic advancements, Carvin Medicines is at the leading edge of creating advanced treatment protocols for functional pain and neurogenic diseases, utilizing novel drug formulations.

Leveraging over 36 years of international drug experience, Carvin Medicines employs proprietary technologies, operational excellence, and in-depth regulatory expertise within the pharmaceutical industry. The company’s primary address is in Toronto, CA, with additional locations in Ticino, CH, and Ha’Arba’a Towers (North), Tel Aviv, IL. Carvin Medicines is committed to improving patient outcomes through cutting-edge research and development.

Carvin Medicines is poised to significantly impact the future of biopharmaceutical treatments. The company aims to continue its growth and further its mission of providing innovative medicines to patients worldwide. We invite the management of Carvin Medicines to create a customized and exclusive company showcase and product listing on our platform to further enhance your visibility and commercial reach.